Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis
Amir Vahedian‐Azimi, Seyede Momeneh Mohammadi, Farshad Beni, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 3, pp. 579-595
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases
Danial Khayatan, Seyed Mehrad Razavi, Zahra Najafi Arab, et al.
Life (2022) Vol. 12, Iss. 5, pp. 760-760
Open Access | Times Cited: 14
The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis
Tannaz Jamialahmadi, Fatemeh Baratzadeh, Željko Reiner, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 13
COVID-19 and Inflammatory Markers
Şevket Balta, İlknur Balta
Current Vascular Pharmacology (2022) Vol. 20, Iss. 4, pp. 326-332
Closed Access | Times Cited: 12
Altered Vascular Endothelium-Dependent Responsiveness in Frail Elderly Patients Recovering from COVID-19 Pneumonia: Preliminary Evidence
Mara Paneroni, Evasio Pasini, Michele Vitacca, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2558-2558
Open Access | Times Cited: 15
Effect of statins on the plasma/serum levels of inflammatory markers in patients with cardiovascular disease; a systematic review and meta-analysis of randomized clinical trials
Mitra Abbasifard, Tahmineh Kandelouei, Saeed Aslani, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 369-383
Closed Access | Times Cited: 11
Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner
Adovich S. Rivera, Omar Al-Heeti, Lucia C. Petito, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Statins and peripheral neuropathy in diabetic and non-diabetic cases: a systematic review
Mahla Daliri, Thomas P. Johnston, Amirhossein Sahebkar
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 5, pp. 593-611
Open Access | Times Cited: 6
The pleiotropic effects of statins inrheumatoid arthritis
Elham Aminifar, Haleh Sadat Tavakkol Afshari, Thozhukat Sathyapalan, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 7, pp. 910-920
Closed Access | Times Cited: 6
Distinct Features of Vascular Diseases in COVID-19
Alexandr Ceasovschih, Victoriţa Şorodoc, Annabelle Shor, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 2783-2800
Open Access | Times Cited: 6
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations
Beatrice A. Golomb, Junhee Han, Peter H. Langsjoen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4659-4659
Open Access | Times Cited: 6
The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2
Simona Fenizia, Melania Gaggini, Cristina Vassalle
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7956-7973
Open Access | Times Cited: 6
Lipid-lowering drugs and cancer: an updated perspective
Azin Alizadehasl, Maryam Sadat Alavi, Shabnam Boudagh, et al.
Pharmacological Reports (2023) Vol. 76, Iss. 1, pp. 1-24
Closed Access | Times Cited: 6
Susceptibility of β-Thalassemia Heterozygotes to COVID-19
Sotirios Sotiriou, Athina A. Samara, Dimitra N. Vamvakopoulou, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3645-3645
Open Access | Times Cited: 13
Role of statins in regulating molecular pathways following traumatic brain injury: A system pharmacology study
Ali Mahmoudi, Sahar Heydari, Yuliya V. Markina, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113304-113304
Open Access | Times Cited: 10
All-cause mortality in COVID-19 patients receiving statin therapy: analysis of veterans affairs database cohort study
Ali El-Solh, Yolanda Lawson, Daniel A. El-Solh
Internal and Emergency Medicine (2021) Vol. 17, Iss. 3, pp. 685-694
Open Access | Times Cited: 12
Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19
Chengyu Liu, Wanyao Yan, Jiajian Shi, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 9
The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials
Seyyed Mostafa Arabi, Mahla Chambari, Mahsa Malekahmadi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1597-1615
Closed Access | Times Cited: 9
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
Pandora L. Wander, Elliott Lowy, Lauren A. Beste, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e058363-e058363
Open Access | Times Cited: 8
Association between Oxidative Burden and Restenosis: A Case-Control Study
Shiva Ganjali, Atena Mansouri, Mitra Abbasifard, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 8
The effects of statins on the function and differentiation of blood cells
Sajjad Chamani, Omid Kooshkaki, Maryam Moossavi, et al.
Archives of Medical Science (2022) Vol. 19, Iss. 5, pp. 1314-1326
Open Access | Times Cited: 8
Impact of Statin or Fibrate Therapy on Homocysteine Concentrations: A Systematic Review and Meta-analysis
Abolfazl Akbari, Muhammad Islampanah, Hadise Arhaminiya, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 14, pp. 1920-1940
Closed Access | Times Cited: 4
The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19
Nafiseh Saghafi, Seyed Abdolrahim Rezaee, Amir Abbas Momtazi‐Borojeni, et al.
Life Sciences (2022) Vol. 294, pp. 120392-120392
Open Access | Times Cited: 7
Berberine: Ins and outs of a nature-made PCSK9 inhibitor.
Sarina Ataei, Prashant Kesharwani, Amirhossein Sahebkar
PubMed (2022) Vol. 21, pp. 1099-1110
Closed Access | Times Cited: 7
Effect of Statins on the Blood Lipid Profile in Patients with Different Cardiovascular Diseases: A Systematic Review with Meta-analysis of Randomized Clinical Trials
Saeed Aslani, Bahman Razi, Danyal Imani, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 32, pp. 3702-3724
Closed Access | Times Cited: 7
Association between the use of statins and in-hospital mortality risk in patients with sepsis-induced coagulopathy during ICU stays: a study based on medical information mart for intensive care database
Yan Yao, Xi Zhao, Mengjue Wang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Scroll to top